Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-VECT Study
NCT04181749Phase 2Recruiting
- Sponsor
- University of Leicester
- Start
- Nov 2020
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin, aspirin in coronary artery disease (CAD), sponsored by University of Leicester. Started Nov 2020; status: recruiting.
02
Drugs
atorvastatinaspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04181749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181749.